SCHEMBL5783509

SCHEMBL5783509

Cc1c(C(=O)N2CCN(C)CC2)nc(-c2ccccc2)n1-c1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.52
ALDH1A1 P00352 7/20 0.50
MAPT P10636 4/20 0.50
HPGD P15428 3/20 0.50
HTT P42858 2/20 0.50
ALOX15 P16050 1/20 0.50
PTPN7 P35236 1/20 0.50
DUSP3 P51452 1/20 0.50
HSD17B10 Q99714 1/20 0.50
APOBEC3G Q9HC16 1/20 0.50
USP2 O75604 1/20 0.49
CA1 P00915 2/20 0.48
CA2 P00918 2/20 0.48
CA9 Q16790 2/20 0.48
NPC1 O15118 1/20 0.48
RAB9A P51151 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
KDM4E B2RXH2 2/20 0.47
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5782959 0.78 MDM2 (0.54) ALDH1A1HTTHSD17B10SMN1; SMN2MEN1
SCHEMBL16404227 0.76 ALDH1A1 (0.52) POLBALDH1A1MAPTHPGDHTT
SCHEMBL2919759 0.74 CNR1 (0.58) POLBALDH1A1MAPTHTTUSP2
SCHEMBL5783789 0.73 ALDH1A1 (0.51) ALDH1A1MAPTHPGDALOX15HSD17B10
SCHEMBL15256984 0.72 POLB (0.57) POLBALDH1A1MAPTHPGDALOX15
SCHEMBL2681081 0.71 GABRA2 (0.58) ALDH1A1MAPTHPGDHSD17B10NPC1
SCHEMBL15256980 0.71 POLB (0.52) POLBALDH1A1MAPTHPGDUSP2
SCHEMBL2913926 0.71 MGLL (0.50) POLBALDH1A1MAPTHTTUSP2
SCHEMBL5785671 0.71 ALDH1A1 (0.58) POLBALDH1A1HTTNPC1RAB9A
SCHEMBL8158988 0.69 POLB (1.00) POLBALDH1A1MAPTHPGDNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060189591-A1 Five-membered heterocyclic derivative DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2006-08-24 US disclosed
EP-1621537-A1 FIVE-MEMBERED HETEROCYCLIC DERIVATIVE DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2006-02-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060189591-A1 Five-membered heterocyclic derivative PTGS1, PTGIS, PTGS2 POLB 3819/4885ALDH1A1 251/4885MAPT 4426/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.